Updated Jul 16, 2026
Williams Eugene has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $141K. Historical track record: 1/5 stars across 4 tracked purchases.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
|---|---|
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 0% |
| 90-day win rate | 0% |
| Avg 5-day return | -318.58% |
| Avg 30-day return | -5058.02% |
| Avg 90-day return | -5771.86% |
| Best 30-day return | -4295.74% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-06 | PMN | ProMIS Neurosciences Inc. | P — Open-market purchase | 2.0K | $24.40 | $49K |
| 2026-03-04 | PMN | ProMIS Neurosciences Inc. | P — Open-market purchase | 2.0K | $24.00 | $48K |
| 2026-03-04 | PMN | ProMIS Neurosciences Inc. | P — Open-market purchase | 1.0K | $21.89 | $22K |
| 2026-03-04 | PMN | ProMIS Neurosciences Inc. | P — Open-market purchase | 1.0K | $22.53 | $23K |
Williams Eugene is a corporate insider — currently tracked as Director of ProMIS Neurosciences Inc. (PMN). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 4 open-market purchases ($141K) and 0 open-market sales () across all tracked filings.
Across 4 tracked purchases, Williams Eugene averaged -5058.0% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Williams Eugene profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.